Table 2.
Univariate predictors of malignant intraductal papillary mucinous neoplasms
| Factors | Benign | Malignant | t/χ2 | P value |
| (n = 16) | (n = 38) | |||
| Gender | ||||
| Male | 10 | 26 | ||
| Female | 6 | 12 | 0.18 | 0.67 |
| Age (yr) | 61.75 ± 7.22 | 61.29 ± 8.72 | -0.18 | 0.85 |
| Lumbodorsal pain | ||||
| Yes | 0 | 3 | ||
| No | 10 | 31 | 1.50 | 0.22 |
| Jaundice | ||||
| Yes | 0 | 19 | ||
| No | 16 | 19 | 12.34 | < 0.01 |
| Direct bilirubin (μmol/L) | ||||
| ≤ 6.0 | 14 | 12 | ||
| > 6.0 | 2 | 26 | 14.10 | < 0.01 |
| ALP (U/L) | ||||
| ≤ 115 | 13 | 12 | ||
| > 115 | 3 | 26 | 9.26 | 0.02 |
| γ-GT (U/L) | ||||
| ≤ 50 | 13 | 10 | ||
| > 50 | 3 | 28 | 13.80 | < 0.01 |
| CA19-9 (U/mL) | ||||
| ≤ 37 | 14 | 8 | ||
| > 37 | 2 | 30 | 20.59 | < 0.01 |
| CEA (ng/mL) | ||||
| ≤ 5 | 15 | 33 | ||
| > 5 | 1 | 5 | 0.54 | 0.65 |
ALP: Alkaline phosphatase; CEA: Carcinoembryonic antigen; CA19-9: Carbohydrate antigen 19-9.